购物车
- 全部删除
- 您的购物车当前为空
iNOs-IN-5(Compound BN-4)作为一种iNOS抑制剂,其IC50值为0.1707 μM,能有效降低LPS (HT-D1056) 刺激下RAW264.7细胞中的NO表达。此外,iNOs-IN-5还能减少缺氧损伤激发的ROS与乳酸脱氢酶的表达,显示其抗坏死及抗凋亡的效果。在SD大鼠的脑缺血模型中,iNOs-IN-5展现了显著的神经保护和抗脑缺血性能,且能透过血脑屏障。
iNOs-IN-5(Compound BN-4)作为一种iNOS抑制剂,其IC50值为0.1707 μM,能有效降低LPS (HT-D1056) 刺激下RAW264.7细胞中的NO表达。此外,iNOs-IN-5还能减少缺氧损伤激发的ROS与乳酸脱氢酶的表达,显示其抗坏死及抗凋亡的效果。在SD大鼠的脑缺血模型中,iNOs-IN-5展现了显著的神经保护和抗脑缺血性能,且能透过血脑屏障。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | iNOs-IN-5 (Compound BN-4) is an inhibitor of iNOS with an IC50 value of 0.1707 μM, effectively reducing NO expression in RAW264.7 cells stimulated by LPS (HT-D1056). It further diminishes the expression of ROS and lactate dehydrogenase induced by hypoxic injury, displaying anti-necrotic and anti-apoptotic properties. In an SD rat model, iNOs-IN-5 exhibits neuroprotective effects against cerebral ischemia and is capable of crossing the blood-brain barrier. |
靶点活性 | iNOS:0.1707 μM |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容